Found 10 matching trials
A Combination Therapy Including Anti-PD-1 Immunotherapy in MSS Rectal Cancer With Resectable Distal Metastasis PHASE2 Although patients with locally advanced rectal cancer and resectable liver/...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
TACE Combined With Sorafenib and Tislelizumab for Advanced HCC PHASE2 This study will evaluate the efficacy and safety of transcatheter arterial ...
Show More Location
The 2nd Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial
TIME in Immunotherapy Combined With nCRT for Rectal Cancer PHASE2 This is an open-label, prospective phase II clinical trial to evaluate the ...
Show More Status
Active Not Recruiting
Location
Peking Union Medical College Hospital
Learn More & Join Trial
Pilot Study of PD-1inhibitor (Tislelizumab) Plus Chemotherapy as Neoadjuvant Therapy for Limited-Stage Small-Cell Lung Cancer PHASE2 This is a phase II, non-randomized, open-label, single-center study to eval...
Show More Location
Shanghai Pulmonary Hospital
Learn More & Join Trial
Neoadjuvant Arterial Embolization Chemotherapy Combined PD-1 Inhibitor for Locally Advanced Rectal Cancer PHASE2 Rectal cancer is one of the common malignant tumors of the digestive tract....
Show More Location
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Learn More & Join Trial
A Combination Therapy Including Anti-PD-1 Immunotherapy in Rectal Cancer With Refractory Distal Metastasis PHASE2 Though surgical resection remains the primary choice for advanced rectal ca...
Show More Learn More & Join Trial
Clinical Trial of OMTX705 in Combination With Gemcitabine/Nab-Paclitaxel and Tislelizumab in Patients With Advanced/Metastatic Pancreatic Adenocarcinoma PHASE1 This is a Phase 1b dose escalation trial of OMTX705, an anti-fibroblast act...
Show More Location
Beth Israel Deaconess Medical Center (BIDMC)
Learn More & Join Trial
Perioperative Immunotherapy for Resectable Limited-Stage SCLC PHASE2 For limited-stage small cell lung cancer (SCLC), surgical treatment is reco...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Futibatinib in Combination With (Chemo)Immunotherapy in Colorectal Cancer and Other Solid Tumor Entities PHASE2 The FUTURE trial is a prospective, multicentre, exploratory, open-label pha...
Show More Location
Klinikum St. Marien Amberg
Learn More & Join Trial
Fruquintinib Combined With PD-1 Inhibitor and FOLFOX as First-Line Treatment For Advanced Gastric Cancer PHASE1 This study was designed to explore the efficacy and safety of fruquintinib ...
Show More Location
The Sixth Affiliated Hospital of Sun Yat-sen University
Learn More & Join Trial